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There is strong agreement between models and field evidence that vector control can reduce 
resurgence and increase the probability of breaking transmission, but current model assumptions 
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Vector control is widely considered an important tool for lymphatic filariasis (LF) elimination but is 
not usually included in programme budgets and has often been secondary to other policy questions 
in modelling studies. Evidence from the field demonstrates that vector control can have a large 
impact on programme outcomes and even halt transmission entirely, but implementation is 
expensive. Models of LF have the potential to inform where and when resources should be focused, 
but often simplify vector dynamics and focus on capturing human prevalence trends, making them 
comparatively ill-designed for direct analysis of vector control measures. We review the recent 
modelling literature and present additional results using a well-established model, highlighting areas 
of agreement between model predictions and field evidence, and discussing the possible 
determinants of existing disagreements. We conclude that there are likely to be long-term benefits 
of vector control, both on accelerating programmes and preventing resurgence.  
 




















Abbreviations: IRS (indoor residual spraying); LLINs (long-lasting insecticide-treated nets); MDA 
(mass drug administration); DEC (diethylcarbamazine); IA (ivermectin and albendazole); DA (DEC and 
albendazole); IDA (ivermectin, DEC and albendazole); EPHP (elimination as a public health problem); 





















Lymphatic filariasis (LF) is a filarial worm infection transmitted by mosquitoes that can lead to 
permanent and debilitating disability if left untreated. Almost 900 million people are at risk of 
infection worldwide and the disease has been targeted for elimination as a public health problem 
(EPHP) by 2030 by the World Health Organization (WHO) [1]. EPHP is an operational definition, 
associated with a population microfilaria prevalence of 1% or antigenemia prevalence of 2% in the 
majority of settings, and is validated using specifically designed Transmission Assessment Surveys 
(TAS) [1]. EPHP validation results in a switch of programme focus to post-validation surveillance 
(PVS). To date, sixteen countries and territories worldwide have been acknowledged as achieving 
EPHP, with preventative chemotherapy still required in 49 countries [1]. 
 
For many vector-borne diseases, such as malaria, substantial gains have been achieved using vector 
control [2,3], however in LF programmes mosquito control is only considered as a supplemental 
measure [1]. The WHO recommended strategy for reducing transmission of LF is a minimum of five 
years of annual mass drug administration (MDA) at 65% coverage in the majority of settings. 
Treatment is usually a combination of diethylcarbamazine and albendazole (denoted DA), or 
ivermectin and albendazole (IA), but recent evidence has led to the WHO also recommending the 
use of all three drugs (IDA) in certain areas that are not co-endemic with onchocerciasis or loiasis, 
such as the Indian Sub-continent [1]. Current WHO guidance supports use of long-lasting insecticide-
treated nets (LLINs) in areas where Anopheles is the primary vector to reduce transmission, but it is 
not required for EPHP validation either during or after cessation of the MDA programme. 
 
The target of EPHP was originally defined as a stepping-stone towards elimination of transmission 


















lower threshold would be required before MDA cessation in the majority of settings if the end goal is 
elimination of transmission [5–7]. True elimination is dependent on a transmission breakpoint – the 
threshold prevalence below which numbers should naturally decline to zero [8].  
 
The existence of a breakpoint is derived from attrition at each stage of the parasite’s life cycle, no 
replication within the vector and the requirement for sexual reproduction in the human host; male 
and female adult worms are required in the same host for mf production, and therefore 
infectiousness [8]. The breakpoint is the threshold prevalence at which the likelihood of sexual 
reproduction in a host drops sufficiently low that sustained transmission is no longer viable. This 
breakpoint depends on a number of factors, including the mosquito biting rate, and reductions in 
biting increase the breakpoint. The threshold biting rate is the lowest biting rate at which 
transmission can be sustained, if it is reduced below this level then case numbers will decline to zero 
no matter how high the starting prevalence is [5].  
 
Mathematical models of transmission have been previously used to derive estimates of breakpoints 
and thresholds for elimination [4,5,9] and have the potential to help inform where and when 
resources, such as vector control, would be best targeted. However, vector control is often a 
secondary consideration and current models are not necessarily designed with analysing vector-
based interventions in mind. In this paper we review the current field evidence and modelling 
literature on vector control usage for lymphatic filariasis control and elimination and discuss how 





















There is strong global evidence that vector control, including bednets, environmental management 
and indoor residual spraying, greatly reduces filariasis prevalence and, in many instances, the effect 
is greater for filariasis than for other vector-borne diseases [10]. The impact of bednets on filariasis 
transmission far exceeds the impact on reducing mosquito biting densities; a study in Kenya showed 
a 22% reduction in biting rates but a 95% reduction in the annual infective biting rate [11]. Another 
study in Papua New Guinea reported a decrease from 61 bites per person per day to 9, and a 
reduction in the annual infective biting rate (AIBR) to zero following the distribution of LLINs [12]. 
 
Some of the strongest evidence of the role of bednets in filariasis elimination is the case of the 
Gambia, where elimination occurred during the scale up of insecticide treated nets, and in the 
absence of any MDA [13]. Bednets not only provide personal and community protection against 
infective bites, they reduce the likelihood of daily survival in mosquitoes and thus the proportion of 
the population that survives through the extrinsic incubation period. 
 
Vector control was the primary control strategy for filariasis before the switch to mass drug 
administration of preventive chemotherapy [10]. There has been renewed enthusiasm to include 
vector control in the Global Programme to Eliminate Lymphatic Filariasis (GPELF) due to challenges 



















Recent modelling:  
To review the recent modelling literature, we searched PubMed using the search term "vector 
control" and "lymphatic filariasis" and either "model", “modelling” or “dynamics” on 22nd October 
2020, for papers published in the last 10 years (since 2010). The search returned 30 publications, 
from which we identified 10 that used mathematical models of lymphatic filariasis transmission to 
assess the impact of vector control on programme outcomes [2,5,6,12,15–20]. Of these studies, four 
used reported vector control coverage data from specific settings and six considered a theoretical 
introduction of vector control at specified coverage levels, most commonly 50% or 80% opulation 
coverage. The majority (7 studies) considered LLINs only, 2 considered LLINs or larval control and 1 
considered a generic impact of vector control, interpreted as LLINs or IRS. Eight studies considered 
vector control in combination with MDA, with a range of drug regimens (IA, DA, DEC salt and/or 
IDA), and two considered the impact of vector control in isolation.  
 
There were three models that appeared multiple times across these studies [5–7,15–18,20]. Two of 
these were stochastic individual-based models that track the unique infection status of individuals 
within a population and the third was a deterministic age-structured model that tracks the mean 
population burden of worms and infective mf stages. However, all three models consider the 
infection dynamics in v ctors as deterministic and implement vector control as a reduction in the 
overall biting rate. 
 
TRANSFIL, one of these stochastic individual-based models, has been fitted to historical data using 
Approximate Bayesian Computation methods and also considers systematic non-compliance of MDA 
[17,18]. Bednets are modelled to have two separate impacts on transmission: they reduce the 


















rate. Individual hosts are modelled distinctly as either protected by a net or not, according to a 
binomial probability equal to assumed coverage, with those who are protected experiencing a lower 
bite rate. However, the impact on the infective larval population in the vector is calculated using a 
deterministic mean-field approach, assuming that net coverage correlates to a proportional mean 
reduction in larval uptake across the vector population.  
 
Results using this model are varied, with one study claiming that 50% vector control may only have a 
small impact on number of rounds of the triple-drug (IDA) required to reach the 1% threshold, with 
no observable difference at low prevalence (10% mf) and approximately one round of difference at 
high prevalence (40% mf) [20]. However, a later study focusing on Papua New Guinea (PNG), which 
used a combination of modelling and field data to consider variable heterogeneity in mosquito-bite 
exposure and infection distributions, found that use of bednets could rapidly reduce the number of 
rounds required [18], aligning better with the existing field evidence. These differences could be due 
to contrasting assumptions around systematic non-adherence or that the second study more 
carefully considers the relationship between host and vector heterogeneities. An additional study 
found that 50% vector control coverage can result in large increases in elimination probability – from 
3% to 97% in some Anopheles settings [17]. 
 
The other stochastic model is LYMFASIM, which has similar host dynamics but uses a deterministic 
non-linear model for the infection dynamics in the vector. The infection level in the vector 
population is derived from the individual mf density and individual exposure to mosquito bites 
across all hosts and is governed by a non-linear relationship between mf intensity in the human 


















Vector control is modelled using similar methods to TRANSFIL, assuming a reduction in the biting 
rate proportional to coverage of the intervention. 
 
In a recent study LYMFASIM predicts implementing 50% coverage vector control will lead to no 
change in the median number of rounds to achieve the EPHP threshold in lower prevalence (10% mf) 
settings, but results do show a reduction in variability between outcomes [20]. The same study 
shows approximately a one round improvement for higher prevalence settings (40% mf), similar to 
TRANSFIL, but a larger decrease in the range of rounds required. 
 
The third model, EPIFIL, is deterministic and uses age-structured partial difference equations to 
describe the mean worm burden and mf levels in humans and an ordinary differential equation to 
describe the infective L3 density in the vector population [19]. LLIN usage is considered to reduce 
the vector to host ratio according to three parameters estimating the deterrence, feeding inhibition 
and toxicity of insecticides [16]. MDA coverage is assumed to be random, with no ability within the 
model to account for systematic non-adherence. 
 
In general, studies using EPIFIL focused on calculating the mf breakpoint and the timelines and 
probabilities for true elimination, with broad conclusions that vector control can have a substantial 
impact on these outcome measures [5,16,19]. One study showed that using 80% coverage vector 
control to increase the mf breakpoint could reduce the number of MDA rounds required to ensure a 
95% probability of elimination by 6 to 15 rounds, with a median decrease of 9 rounds, and could 
reduce the variance from 3.52 to 2.66 in Anopheles settings [16]. A recent study using vector control 
and infection data from a range of settings demonstrated that maintaining vector control at current 


















whereas the one setting investigated that had no vector control had a much lower elimination 
probability of 24% [15]. 
 
However, other studies suggest only a small impact of increasing LLIN coverage to 80% on 
elimination year and no discernible difference on rounds of IDA treatment to 1% mf prevalence 
between no vector control and 50% vector control for either low or high prevalence settings [6,20]. 
Modelling also found only very minor gains from increasing vector control coverage from 50% to 
80% on additional rounds required to get from 1% mf to the actual breakpoint required for true 
elimination [7]. This may be due to the lack of systematic non-adherence in the model resulting in an 
overestimation in the impact of MDA on prevalence, which may give a lower comparative effect of 
vector control. 
 
The other two studies used different modelling assumptions. A data-driven study based in PNG that 
used xeno-monitoring methods to quantify the prevalence of infection and infectiousness in the 
vector population found no infectious vectors following LLIN distribution and used Bayesian 
modelling methods to conclude that transmission had been interrupted in all locations [12]. The 
second study used a simple differential equation model to consider the worm burden in the human 
population and concluded that relatively modest vector control coverage (36%) could lead to LF 
elimination without any requirement for MDA [2], which supports findings from The Gambia [13]. 
 
Methods 
We used one of the previously discussed models of LF transmission, TRANSFIL, a stochastic 


















including vector density and biting rate, parasite life cycle and human exposure to vectors [17,22]. A 
proportion of the host population, equal to the chosen vector control coverage, are considered to be 
protected by either LLINs or IRS and therefore experience reduced transmission of infective larvae 
from mosquitoes. Uptake of new infectious larval infections in the vector population is considered to 
be reduced in proportion to modelled vector control coverage. The annual biting rate in the absence 
of vector control was varied between 0 and 1200 bites per person per year and the aggregation 
parameter for bite risk, k, between 0.01 and 0.1. 
 
Our results focus on moderate mf prevalence (10% ±1%) settings with Anopheles as the dominant 
vector, as these are the areas where vector control is expected to have most utility. Annual MDA 
using IA is simulated every 12 months at 65% coverage until mf prevalence is below 1% for a full year 
post-MDA, at which point MDA is halted and the model is then run for a further 10 years. Systematic 
non-adherence to MDA is included in the model by calculating individual probabilities of receiving 
MDA based on coverage and a between-round correlation parameter [23]. 
  
To investigate the impact of vector control on different stages of LF elimination, we simulated four 
main combinations of this MDA regimen and different vector control strategies: 1. No vector control 
(counterfactual); 2. 50% vector control coverage during MDA, sustained at same levels post-EPHP; 3. 
50% vector control coverage during MDA, enhanced to 80% coverage post-EPHP; 4. 50% vector 
control coverage during MDA but no maintenance of vector control post-EPHP, leading to waning 
effects on transmission (see Supplementary Materials). The primary vector control method 



















Model outcomes were categorised using a Pearson’s correlation test between time and the mf 
prevalence across the first 9 years following MDA cessation; if correlation was significant (p=0.01) 
then a positive correlation coefficient was taken to represent increasing prevalence (‘resurgence’) 
and a negative correlation to represent prevalence decreasing towards zero (‘true elimination’). In a 
small proportion of scenarios correlation was found to be not significant (p>0.01) and this was 




The impact of vector control on the number of MDA rounds required to reach EPHP levels is 
dependent on assumptions about systematic non-adherence to MDA (Figure 1). Implementing 50% 
coverage vector control alongside MDA, assuming no systematic non-adherence, reduces the 
median number of rounds from 11 to 10 and the mean from 11 to 9 rounds. Although this is a 
comparatively small average impact, vector control does have a substantial effect on variability in 
the number of rounds required to achieve EPHP, with a reduction in the IQ range from 8-14 to 8-11 
and a reduction in the upper 95% quantile from 18 to 13 rounds.  
 
For systematic non-adherence correlation of 0.35, 50% vector control gives a difference of three 
rounds between the median number of rounds to reach the EPHP threshold: 16 (IQR: 12-22) for 
MDA only, 13 (IQR: 10-16) for MDA and 50% vector control. Assuming a very high level of systematic 
non-adherence correlation, 0.7, implementing 50% coverage vector control alongside MDA reduces 



















Looking at mf prevalence over time during and post-MDA shows clear trends between vector control 
usage and long-term dynamics of lymphatic filariasis transmission (Figure 2). Enhancing vector 
control after MDA cessation can reduce the risk of resurgence and keep prevalence at low levels. 
However, vector control used during an MDA programme that is not maintained following EPHP 
validation could accelerate resurgence. 
 
After MDA cessation vector control usage has a substantial impact on long-term outcomes (Figure 
3). In the model maintaining 50% coverage vector control after reaching EPHP prevalence levels and 
stopping MDA reduced the risk of resurgence (increasing transmission) from 72.9% to 50.4% and 
more than doubled the probability of true elimination (decreasing transmission towards zero) from 
22.8% to 42.9%. Enhancing coverage from 50% to 80% also had a large benefit, reducing the risk of 
resurgence to 15.9% and increasing the probability of elimination to 78.4%. 
 
Discussion 
We found a number of areas of agreement between modelling and field evidence for vector control. 
In particular, reports of vector control being successfully used to interrupt transmission in the field 
[12,13] are supported by model predictions that reducing the biting rate could greatly increase the 
probability of elimination and decrease the probability of resurgence [2,15,17]. Our results also 
demonstrate the utility of enhancing vector control coverage after MDA cessation and that poorly 
maintained vector control could undermine hard-won gains. 
 
However, modelling studies are variable in their assessment of the predicted impact of vector 
control on the required duration of MDA programmes to achieve a threshold of 1% mf prevalence. A 


















coverage [6,20], but these findings are not consistent across all recent modelling [18]. We have 
demonstrated that this inconsistency could be partially due to the choice of key parameters, such as 
the level of systematic non-adherence. Lower systematic non-adherence results in more effective 
MDA interventions and a lower relative impact of vector control on number of rounds to the 
threshold, whereas high systematic non-adherence is associated with a higher relative impact of 
vector control. 
 
Current modelling methods are limited by largely simplified assumptions around the vector 
dynamics, potentially resulting in an underestimation of vector control impact. Most models assume 
vector control provides a reduction in biting, either on average across the population or for 
individual protected hosts, and a reduced overall uptake in mf by the vector population [20]. 
However, none of the models discussed consider the age-structure of the vector population, or how 
this changes under the pressures of vector control. For example, LLIN usage deters biting and 
increases mortality in blood-seeking mosquitoes, which will translate to a younger vector population 
that each take fewer successful blood meals across their lifespan. As a result, fewer infected vectors 
would survive the extrinsic incubation period to infectivity, which is not captured in current 
modelling methods and could explain some of the discrepancies between model predictions and the 
field evidence. 
 
Models are also currently not generally well-validated for low prevalence, but we know the 
qualitative dynamics are able to emulate a range of scenarios. In particular, modelling has 
demonstrated that there is a long tail to elimination [4], supporting observations of low-level 
maintenance in countries that have achieved EPHP [25], and agrees with findings that vector control 



















Despite overall agreement that vector control has demonstrable benefits for LF control and 
elimination, the areas of difference we have discussed between the field evidence and modelling 
results are indicative of how modelling methods could be built on in the future to better address the 
utility of vector control. As more countries approach EPHP validation, there is a greater need than 
ever to understand the determinants of elimination. Explicit inclusion of vector population structure 
and dynamics in models of LF transmission would enable more focused and detailed analysis into 
how, where and when vector control resources are best directed. 
 
Conclusions 
Although models and field data currently provide conflicting messages on the magnitude of any 
potential impact of vector control during MDA, there is a strong agreement between the modelling 
literature and the field evidence that vector control is highly beneficial post-MDA in reducing 
resurgence and increasing the probability of elimination of transmission. We conclude that it is vital 
that existing vector control interventions are well-maintained after MDA cessation, and that there is 
likely to be substantial long-term benefit to implementing enhanced vector control coverage 
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Figure 1: Modelled impact of vector control on MDA rounds to EPHP. The number of rounds of 
MDA (65% IA, Anopheles settings) required to reach EPHP (1% mf prevalence) from a baseline 
prevalence of 9-11% (aggregation k from 0.01 to 0.1 and ABR from 0 to 1200). MDA only (red) and 
MDA with 50% vector control coverage (orange) and a range of assumptions around systematic non-
adherence: a) No systematic non-adherence; b) moderate systematic non-adherence (correlation 
0.35); c) high systematic non-adherence (correlation 0.7). 
 
Figure 2: Modelled impact of vector control on elimination and resurgence trajectories. Mean mf 
prevalence for scenarios with 65% coverage of IA and 50% coverage vector control during MDA 
(Anopheles settings, 9-11% baseline mf prevalence) that reach EPHP in 10 rounds. Following MDA 
cessation three scenarios are considered: waning vector control efficacy due to poor or no 
maintenance (red, solid); vector control maintained consistently at 50% coverage (orange, dashed); 
enhanced 80% coverage vector control (green, dotted).  
 
Figure 3: Modelled impact of vector control on probabilities of elimination and resurgence. 
Probability of resurgence (left), low-level maintenance (centre) and true elimination (right) following 
EPHP validation and MDA cessation for Anopheles settings with a 9-11% baseline prevalence. 
Following MDA cessation three scenarios are considered: waning vector control efficacy due to poor 
or no maintenance (red, left); vector control maintained consistently at 50% coverage (orange, 
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